Drivers of Inflammation in Psoriatic Arthritis: the Old and the New
Drivers of Inflammation in Psoriatic Arthritis: the Old and the New
复制标题
银屑病关节炎炎症的驱动因素:新旧
DOI:
10.1007/s11926-021-01005-x
复制
发表时间:
2021-06-01
影响因子:
5
通讯作者:
Kirkham, Bruce W.
中科院分区:
文献类型:
--
作者:
O'Brien-Gore, Charlotte;Gray, Elizabeth H.;Kirkham, Bruce W.
Purpose of Review The recognition that IL-17 is produced by many lymphoid-like cells other than CD4+ T helper (Th17) cells raises the potential for new pathogenic pathways in IBD/psoriasis/SpA. We review recent knowledge concerning the role of unconventional and conventional lymphocytes expressing IL-17 in human PsA and axSpA. Recent Findings Innate-like lymphoid cells, namely gamma delta (gamma delta) T-cells, invariant natural killer T (iNKT) cells and mucosal-associated invariant T (MAIT) cells, together with innate lymphoid cells (ILCs) are found at sites of disease in PsA/SpA. These cells are often skewed to Type-17 profiles and may significantly contribute to IL-17 production. Non-IL-23 dependent IL-17 production pathways, utilising cytokines such as IL-7 and IL-9, also characterise these cells. Both conventional CD4 and CD8 lymphocytes show pathogenic phenotypes at sites of disease. A variety of innate-like lymphoid cells and conventional lymphocytes contribute towards IL-17-mediated pathology in PsA/SpA. The responses of these cells to non-conventional immune and non-immune stimuli may explain characteristic clinical features of these diseases and potential therapeutic mechanisms of therapies such as Jak inhibitors.